Rising seafood prices and unprofitable locations threaten the chain’s recovery, with bankruptcy risk looming.
Lipella Pharmaceuticals Inc. ('Lipella” or the 'Company”), a clinical-stage biotechnology company, announced today that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results